The purpose of this multi-centered, NIH-sponsored study is to develop an optimal protocol for using noninvasive 129Xe gas exchange MRI to detect changing disease activity in interstitial lung diseases (ILDs).
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Thoracic Cavity Volume Measured in Liters
Timeframe: 1 day (immediately after administration of hyperpolarized 129 Xenon)
RBC/Barrier Signal Ratio (Unitless).
Timeframe: 1 day (immediately after administration of hyperpolarized 129 Xenon)
Coefficient of Repeatability of RBC/Barrier Signal Ratio (Unitless).
Timeframe: 1 day (immediately after administration of hyperpolarized 129 Xenon)
Echo Time to Separate RBC and Barrier Signals by 90 Degrees (ms).
Timeframe: 1 day (immediately after administration of hyperpolarized 129 Xenon)
Population-wide RBC/Barrier Signal Ratio (Unitless).
Timeframe: 1 day (immediately after administration of hyperpolarized 129 Xenon)